United States: Denosumab Clinical Trial Updates - Goodwin Procter LLP
Mondaq,
The Big Molecule Watch is monitoring Phase III clinical trials involving denosumab biosimilars.
The Big Molecule Watch is monitoring Phase III clinical trials involving denosumab biosimilars.
The study of postmenopausal women in Iran found the efficacy of the biosimilar was noninferior to the reference product and the…